Carolinas Wealth Consulting’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-54
| Closed | -$2K | – | 891 |
|
|
2022
Q2 | $2K | Hold |
54
| – | – | ﹤0.01% | 754 |
|
|
2022
Q1 | $2K | Hold |
54
| – | – | ﹤0.01% | 791 |
|
|
2021
Q4 | $2K | Sell |
54
-2
| -4% | -$74 | ﹤0.01% | 820 |
|
|
2021
Q3 | $3K | Hold |
56
| – | – | ﹤0.01% | 735 |
|
|
2021
Q2 | $4K | Buy |
56
+22
| +65% | +$1.57K | ﹤0.01% | 720 |
|
|
2021
Q1 | $3K | Sell |
34
-3
| -8% | -$265 | ﹤0.01% | 765 |
|
|
2020
Q4 | $3K | Sell |
37
-27
| -42% | -$2.19K | ﹤0.01% | 696 |
|
|
2020
Q3 | $7K | Buy |
+64
| New | +$7K | ﹤0.01% | 524 |
|